NO20013901L - Unsaturated cholesterol derivatives and their use in the preparation of meiosis-regulating drugs - Google Patents

Unsaturated cholesterol derivatives and their use in the preparation of meiosis-regulating drugs

Info

Publication number
NO20013901L
NO20013901L NO20013901A NO20013901A NO20013901L NO 20013901 L NO20013901 L NO 20013901L NO 20013901 A NO20013901 A NO 20013901A NO 20013901 A NO20013901 A NO 20013901A NO 20013901 L NO20013901 L NO 20013901L
Authority
NO
Norway
Prior art keywords
meiosis
cholesterol derivatives
preparation
unsaturated cholesterol
regulating drugs
Prior art date
Application number
NO20013901A
Other languages
Norwegian (no)
Other versions
NO20013901D0 (en
Inventor
Thorsten Blume
Peter Esperling
Joachim Kuhnke
Christa Hegele-Hartung
Monika Lessl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20013901L publication Critical patent/NO20013901L/en
Publication of NO20013901D0 publication Critical patent/NO20013901D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse angår farmasøytiske aktive umettede kolestanderivater, farmasøytiske sammensetninger omfattende disse som aktive substanser og anvendelse av disse nye forbindelsene for fremstilling av medikamenter. Nærmere bestemt er det blitt funnet at umettede kolestanderivater ifølge oppfinnelsen kan anvendes ved regulering av meiose.The present invention relates to pharmaceutically active unsaturated cholesterol derivatives, pharmaceutical compositions comprising these as active substances and the use of these novel compounds for the manufacture of medicaments. More specifically, it has been found that unsaturated cholesterol derivatives of the invention can be used in the control of meiosis.

NO20013901A 1999-02-10 2001-08-10 Unsaturated cholesterol derivatives and their use in the preparation of meiosis-regulating drugs NO20013901D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99250040 1999-02-10
PCT/EP2000/001074 WO2000047604A1 (en) 1999-02-10 2000-02-09 Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments

Publications (2)

Publication Number Publication Date
NO20013901L true NO20013901L (en) 2001-08-10
NO20013901D0 NO20013901D0 (en) 2001-08-10

Family

ID=8241140

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013901A NO20013901D0 (en) 1999-02-10 2001-08-10 Unsaturated cholesterol derivatives and their use in the preparation of meiosis-regulating drugs

Country Status (15)

Country Link
EP (1) EP1150993A1 (en)
JP (1) JP2002536456A (en)
KR (1) KR20010101820A (en)
CN (1) CN1368977A (en)
AU (1) AU3279700A (en)
BR (1) BR0008065A (en)
CA (1) CA2359687A1 (en)
CZ (1) CZ20012866A3 (en)
HU (1) HUP0200280A2 (en)
IL (1) IL143735A0 (en)
NO (1) NO20013901D0 (en)
PL (1) PL350557A1 (en)
SK (1) SK11382001A3 (en)
WO (1) WO2000047604A1 (en)
ZA (1) ZA200107387B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
RU2188006C2 (en) * 1995-03-06 2002-08-27 Ново Нордиск А/С Stimulation of meiosis
PL185622B1 (en) * 1995-06-23 2003-06-30 Novo Nordisk As Meiosis controlling compounds
EP0946584B1 (en) * 1996-12-20 2003-04-23 Novo Nordisk A/S Meiosis regulating compounds

Also Published As

Publication number Publication date
EP1150993A1 (en) 2001-11-07
IL143735A0 (en) 2002-04-21
CZ20012866A3 (en) 2002-01-16
CA2359687A1 (en) 2000-08-17
PL350557A1 (en) 2002-12-16
BR0008065A (en) 2001-11-06
HUP0200280A2 (en) 2002-07-29
NO20013901D0 (en) 2001-08-10
WO2000047604A1 (en) 2000-08-17
ZA200107387B (en) 2002-12-06
AU3279700A (en) 2000-08-29
SK11382001A3 (en) 2002-01-07
JP2002536456A (en) 2002-10-29
KR20010101820A (en) 2001-11-14
CN1368977A (en) 2002-09-11

Similar Documents

Publication Publication Date Title
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
NO20062504L (en) Compositions and dosage forms for improved absorption
HUP0302131A2 (en) Pharmaceutical tramadol salts, pharmaceutical compositions containing them
EP1820503A3 (en) Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
NO20040547L (en) Amino-phthalazine derivatives active as kinase inhibitors, processes for their preparation, and pharmaceutical compositions containing them.
GB0102687D0 (en) Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
MXPA06000302A (en) Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
NO20054842L (en) Chemical connections
ATE386725T1 (en) HETEROCYCLYL COMPOUNDS
WO2005014572A8 (en) Pyrimidylpyrrole derivatives active as kinase inhibitors
IL163951A0 (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
SE0102440D0 (en) New compound
DE60102590T2 (en) PHARMACEUTICAL FORMS FOR THE TREATMENT OF ORAL MYCOSES
NO20054417L (en) Process for the preparation of pharmaceutical preparations in the form of fibrate-containing tablets and the tablets thus prepared
NO323466B1 (en) New quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives, processes for their preparation, use thereof in medicaments for the treatment of pain, and pharmaceutical compositions comprising such derivatives
NO20013901L (en) Unsaturated cholesterol derivatives and their use in the preparation of meiosis-regulating drugs
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
DK1492539T3 (en) Statin therapy to enhance cognitive function
WO2001089282A3 (en) 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
SE9902936D0 (en) Pharmaceutical compositions
NO20015488L (en) 14 <beta> -H-sterols, pharmaceutical compositions comprising them, and the use of these derivatives for the preparation of bio-regulating drugs
WO2002006299A3 (en) Therapeutic uses for aminosterol compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application